Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ADAG stock hub

Adagene Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ADAGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

243.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ADAG

In the news

Latest news · ADAG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-34.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ADAG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001818838
Company name	Adagene Inc.
Country	China
Country code	US
Cusip	005329107
Employees	128
Employees Change	-10%
Employees Change Percent	-7.25
Enterprise value	$174.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-09
Isin	US0053291078
Last refreshed	2026-05-10
Market cap	$243.8M
Market cap category	Micro-Cap
Price	$3.69
Price currency	USD
Rev Per Employee	59,928.92x
Sector	Healthcare
Sic	2834
Symbol	ADAG
Website	https://www.adagene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.22%
EV/Sales	22.71x
FCF yield	-6.43%
P/B ratio	4.95x
P/S ratio	31.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-279.48%
EBITDA Margin	-273.75%
Gross margin	100%
Gross Profit	$7.7M
Gross Profit Growth	7,332.76%
Gross Profit Growth Q	840.35%
Gross Profit Growth3 Y	-6.19%
Gross Profit Growth5 Y	61.38%
Net Income	$-17.6M
Net Income Growth Years	1%
Pretax Margin	-233.44%
Profit Margin	-229.56%
Profit Per Employee	$-137,574
ROA	-16
Roa5y	-22.54
ROCE	-40.38
ROE	-34.39
Roe5y	-49.41
ROIC	-21.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	130.76%
Cagr3y	40.15%
Cagr5y	-21.84%
EPS Growth Years	1
Revenue Growth	7,332.76x
Revenue Growth Q	7,332.76x
Revenue Growth Years	1x
Revenue Growth3 Y	-6.19x
Revenue Growth5 Y	61.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$78.3M
Cash	$75.8M
Current Assets	$77.4M
Current Liabilities	$25.2M
Debt	$6.3M
Debt Equity	$0.12
Equity	$51.9M
Interest Coverage	-46.29
Liabilities	$26.4M
Long Term Assets	$888,132
Long Term Liabilities	$1.2M
Net Cash	$69.6M
Net Cash By Market Cap	$28.54
Net Cash Growth	-20.59%
Net Debt Equity	$-1.34
Tangible Book Value	$35.3M
Tangible Book Value Per Share	$0.75
WACC	7.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.07
Net Working Capital	$-18.6M
Quick ratio	3.01
Working Capital	$52.2M
Working Capital Turnover	$0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.83%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	130.63%
200-day SMA	2.5
3Y total return	175.37%
50-day SMA	3.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-70.83%
All Time High	31.83
All Time High Change	-88.41%
All Time High Date	2021-02-11
All Time Low	0.9
All Time Low Change	310%
All Time Low Date	2022-10-25
ATR	0.32
Beta	0.57
Beta1y	0.05
Beta2y	0.35
Ch YTD	95.24
High	3.74
High52	4.75
High52 Date	2026-04-07
High52ch	-22.32%
Low	3.4
Low52	1.3
Low52 Date	2025-11-07
Low52ch	183.85%
Ma50ch	-0.14%
Price vs 200-day SMA	47.9%
RSI	49.33
RSI Monthly	57.63
RSI Weekly	61.43
Sharpe ratio	1.29x
Sortino ratio	2.23
Total Return	-4.83%
Tr YTD	95.24
Tr1m	-16.7%
Tr1w	-3.4%
Tr3m	40.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$8.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.61
Earnings Revenue Estimate	1,666,670x
Earnings Revenue Estimate Growth	1,514.93x
Operating Income	$-21.4M
Operating margin	-279.5
Price target	$8.25
Price Target Change	$124
Price Target Change Top	$130

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,179,015%
Float Percent	69.89%
Net Borrowing	-12,242,905
Shares Insiders	11.4%
Shares Institutions	13.17%
Shares Out	66,072,594
Shares Qo Q	0.39%
Shares Yo Y	4.83%
Short Ratio	1.29
Short Shares	0.73

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-19.4M
Average Volume	210,095.6x
Bv Per Share	0.75
CAPEX	$-17,053
Ch1m	-16.7
Ch1w	-3.4
Ch1y	130.6
Ch3m	40.3
Ch3y	175.4
Ch5y	-70.83
Ch6m	162.6
Change	3.07%
Change From Open	1.93
Close	3.58
Days Gap	1.12
Depreciation Amortization	438,864
Dollar Volume	381,796.9
Earnings Date	2026-04-01
Earnings Time	amc
EBIT	$-21.4M
EBITDA	$-21M
EPS	$-0.38
F Score	3
FCF	$-15.7M
FCF EV Yield	-9x
FCF Per Share	$-0.24
Financing CF	4,445,374
Fiscal Year End	December
Founded	2,011
Income Tax	$-297,860
Investing CF	476,803
Ipr	-80.58
Iprfo	-81.91
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-01
Ma150	2.63
Ma150ch	40.41%
Ma20	3.73
Ma20ch	-0.94%
Net CF	-10,670,720
Next Earnings Date	2026-08-11
Open	3.62
Optionable	No
Position In Range	85.29
Ppne	862,909
Price Date	2026-05-08
Ptbv Ratio	6.9
Relative Volume	0.49x
Revenue	7,670,902x
SBC By Revenue	48.78x
Share Based Comp	3,741,548
Tax By Revenue	-3.88x
Tr6m	162.63%
Volume	103,468
Z Score	-3.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ADAG pay a dividend?

Capital-return profile for this ticker.

Performance

ADAG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ADAG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.2%

Float: +69.9% of shares outstanding

Insider ownership

+11.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ADAG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.3

Neutral momentum band

Price vs 200-day MA

+47.9%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

1.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ADAG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ADAG stock rating?

Adagene Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ADAG analysis?

The full report lives at /stocks/ADAG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ADAG?

The latest report frames ADAG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ADAG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.